AdvaMed Names Dean Paranicas Chair of State Medical Technology Alliance
The Advanced Medical Technology Association (AdvaMed) has named HINJ President and Chief Executive Officer Dean J. Paranicas to be chair of AdvaMed’s State Medical Technology Alliance (SMTA). Beginning his term in January 2019, Dean is the sixth leader to serve as SMTA chair. He will build on the initiatives established by immediate past SMTA Chair Shaye Mandle of Medical Alley Association (2015-2018).
SMTA is a consortium of state and regional trade associations representing local medical technology companies. SMTA’s mission is to provide collective support for the medical technology industry on the local, state and national levels by fostering a collaborative environment through sharing of best practices, promoting the industry, and advocating for public policies that support innovation.
AdvaMed is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. With over 400 members and more than 80 employees, AdvaMed has a global presence in countries including Europe, India, China, Brazil and Japan.
AdvaMed’s member companies range from the largest to the smallest medical technology innovators and companies. The Association acts as the common voice for companies producing medical devices, diagnostic products and health information systems.
Statement on the U.S.-Mexico-Canada Agreement from Dean J. Paranicas, HINJ President and Chief Executive Officer
“The HealthCare Institute of New Jersey (HINJ) and its member companies applaud the proposed United States-Mexico-Canada Agreement on trade for strengthening intellectual property protections that will reinforce America’s global leadership in research and development. These protections will enable the continued medical innovation that is the lifeblood of our biopharmaceutical and medical technology community. We are hopeful for similar agreements in the future that expand the horizons for medical innovation in other parts of the world.”
HINJ Honors Innovative Program at the New Jersey Institute of Technology
HINJ recently presented its 2018 Life Sciences Recognition Award for Innovation to the Garden Practice Transformation Network, a unit of the Healthcare Delivery Systems iLab, “in recognition of contributions and leadership in improving healthcare delivery and patient outcomes.”
The network has more than 10,000 physicians and has achieved more than $138 million in savings, so far. The iLab is part of the New Jersey Innovation Institute at the New Jersey Institute of Technology.
The presentation was made September 27, at the annual DV/NJ Healthcare Information Management Systems Society Fall Event.
You can read more about the iLab in a recent ROI-NJ story.
HINJ honors New Brunswick Health Sciences Technology High School
HINJ recently presented its 2018 Recognition Award for Leadership & Achievements in STEM Education to the New Brunswick Health Sciences Technology High School. Congratulations to the school’s entire community!
We Work For Health New Jersey Team Participates in 2018 National Summit
HealthCare Institute of New Jersey Announces New Board and Steering Committee Leadership
The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1.
Alex Kelly, who is Executive Vice President, Corporate Affairs, Allergan, has been elected Chair of the HINJ Board of Trustees. He previously served as Treasurer.
Mr. Kelly has been an EVP and the Chief Communications Officer at Allergan since 2015. Previously, he served as Senior Vice President, Chief Integration Officer since July 2014. In this role, he led the integration of Forest Laboratories and co-led the integration of Allergan, Inc. following Actavis’ acquisition of each company. Prior to joining Actavis, Mr. Kelly was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Laboratories. Previously, Mr. Kelly served as Vice President, Investor Relations at Bausch + Lomb and he was Senior Vice President, Investor Relations at Merck & Co., Inc. He earned his Bachelor of Science in Pharmacy from Purdue University, where he graduated Cum Laude.
Mr. Kelly succeeds Yin Becker, Vice President, Communications and Public Affairs, Stryker. Ms. Becker continues to serve HINJ as Immediate Past Chair.
Also at its May 15 meeting, the HINJ Board elected Dan Casserly, U.S. Country Head, Government Affairs, Novartis Services, Inc., to serve as Vice Chair. The new Treasurer is Steven Immergut, Vice President and Head of Communications and Advocacy Relations, Pharmaceuticals, Bayer. Lisa M. Goldman continues to serve as Board Secretary.
HINJ also has announced that Loredana Cromarty, Associate Vice President, Government Affairs, Allergan, has been appointed Chair of the HINJ Steering Committee. The new Vice Chair is Wendy Lazarus, Director, State Government Relations, Pfizer, Inc.
ALSIC Honors Rep. Bonnie Watson Coleman
HINJ Media Contact:
Edward F. Tate III
Director of Communications
732-729-9619, ext. 344